Embracing sustainable change through labelling choice

Published: 17-Nov-2025

Paavo Sillanpää, Senior Manager, Ecosystem Pharma and Healthcare, EMEIA, UPM Adhesive Materials, discusses the latest trends in pharmaceutical packaging and labelling and how producers can embrace future-focused solutions and sustainable options without compromising performance

You need to be a subscriber to read this article.
Click here to find out more.

The increasing prevalence of chronic conditions such as diabetes means that injectables are now the fastest-growing packaging segment.

Embracing sustainable change through labelling choice

Alongside this, the rise in self-medication — owing to the ever-increasing cost of healthcare — has seen growing demand for injection pens, prefilled syringes, on-body injectors and monitoring.

Add to this the popularity of weight loss drugs and it’s no surprise that demand for delivery systems, such as prefilled syringes, ampoules, vials, cartridges and injection pens, is on a growth curve.

The COVID legacy has also led to a rise in the use of vaccines that must be stored at –80 °C  … with the subsequent challenges that are placed on packaging and labelling alike.

Last but not least, the wearable device market is an area to watch as consumers continue to focus on managing their own health.  

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like